UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (6), p.2457-2464

2005

Volltextzugriff (PDF)

Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma

Clinical cancer research, 2004-07, Vol.10 (13), p.4332-4341

2004

Volltextzugriff (PDF)

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

International journal of cancer, 2003-01, Vol.103 (2), p.205-211

2003

Volltextzugriff (PDF)

An Immunodominant MHC Class II-Restricted Tumor Antigen Is Conformation Dependent and Binds to the Endoplasmic Reticulum Chaperone, Calreticulin

The Journal of immunology (1950), 2001-07, Vol.167 (1), p.147-155

2001

Volltextzugriff (PDF)

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma

World journal of gastroenterology : WJG, 2006-05, Vol.12 (20), p.3275

2006

Volltextzugriff (PDF)

Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

Journal of hepatology, 2019-03, Vol.70 (3), p.449-457

2019

Volltextzugriff (PDF)

S100A9 a new marker for monocytic human myeloid‐derived suppressor cells

Immunology, 2012-06, Vol.136 (2), p.176-183

2012

Volltextzugriff (PDF)

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

Journal of hepatology, 2017-03, Vol.66 (3), p.545-551

2017

Volltextzugriff (PDF)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

BMC cancer, 2010-05, Vol.10 (1), p.209-209, Article 209

2010

Volltextzugriff (PDF)

CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice

The Journal of immunology (1950), 2010-07, Vol.185 (1), p.203-210

2010

Volltextzugriff (PDF)

Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice

Journal of leukocyte biology, 2012-12, Vol.92 (6), p.1199-1206

2012

Volltextzugriff (PDF)

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

Hepatology (Baltimore, Md.), 2009-09, Vol.50 (3), p.799-807

2009

Volltextzugriff (PDF)

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+ CD25+ Foxp3+ T Cells

Gastroenterology (New York, N.Y. 1943), 2008-07, Vol.135 (1), p.234-243

2008

Volltextzugriff (PDF)

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

Cancer Immunology, Immunotherapy, 2019-04, Vol.68 (4), p.599-608

2019

Volltextzugriff (PDF)

Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer

Hepatology (Baltimore, Md.), 2019-05, Vol.69 (5), p.2048-2060

2019

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway

Gastroenterology (New York, N.Y. 1943), 2008-09, Vol.135 (3), p.871-881.e5

2008

Volltextzugriff (PDF)

Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage

PloS one, 2014-11, Vol.9 (11), p.e112717-e112717

2014

Volltextzugriff (PDF)

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage

Cancer immunology research, 2015-05, Vol.3 (5), p.557-566

2015

Volltextzugriff (PDF)

Peptidases released by necrotic cells control CD8+ T cell cross-priming

The Journal of clinical investigation, 2013-11, Vol.123 (11), p.4755-4768

2013

Volltextzugriff (PDF)

Necrotic Tumor Cell Death In Vivo Impairs Tumor-Specific Immune Responses

Journal of Immunology, 2007-02, Vol.178 (3), p.1573-1580

2007

Volltextzugriff (PDF)

Tumor‐induced CD11b+ Gr‐1+ myeloid‐derived suppressor cells exacerbate immune‐mediated hepatitis in mice in a CD40‐dependent manner

European journal of immunology, 2015-04, Vol.45 (4), p.1148-1158

2015

Volltextzugriff (PDF)

IFN‐γ regulates survival and function of tumor‐induced CD11b+Gr‐1high myeloid derived suppressor cells by modulating the anti‐apoptotic molecule Bcl2a1

European journal of immunology, 2014-08, Vol.44 (8), p.2457-2467

2014

Volltextzugriff (PDF)

Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells

Cellular oncology : the official journal of the International Society for Cellular Oncology, 2008, Vol.30 (6), p.463-471

2008

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(15)
Male
(13)
Animals
(12)
Mice
(11)
Aged
(10)
Immunology
(10)
Middle Aged
(10)
Myeloid Cells - Immunology
(10)
Mice, Inbred Balb C
(9)
Carcinoma, Hepatocellular - Immunology
(8)
Liver Neoplasms - Immunology
(8)
Mice, Inbred C57bl
(8)
Adult
(7)
Cell Line, Tumor
(7)
Gastroenterology & Hepatology
(7)
Oncology
(7)
Cd4-Positive T-Lymphocytes - Immunology
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma

Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo

An Immunodominant MHC Class II-Restricted Tumor Antigen Is Conformation Dependent and Binds to the Endoplasmic Reticulum Chaperone, Calreticulin

Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma

Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

S100A9 a new marker for monocytic human myeloid‐derived suppressor cells

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice

Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor

A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+ CD25+ Foxp3+ T Cells

The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway

Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage

Peptidases released by necrotic cells control CD8+ T cell cross-priming

Necrotic Tumor Cell Death In Vivo Impairs Tumor-Specific Immune Responses

Tumor‐induced CD11b+ Gr‐1+ myeloid‐derived suppressor cells exacerbate immune‐mediated hepatitis in mice in a CD40‐dependent manner

IFN‐γ regulates survival and function of tumor‐induced CD11b+Gr‐1high myeloid derived suppressor cells by modulating the anti‐apoptotic molecule Bcl2a1

Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells

Aktive Filter

Suchergebnisse filtern